2021
DOI: 10.1080/02713683.2021.1878229
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Demographic Characteristics of Tearing in Patients after Radioiodine Ablation for Differentiated Thyroid Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 13 publications
0
4
0
3
Order By: Relevance
“…According to the study, SALDO occurs in 8.8% of patients after a single high-dose radioactive iodine therapy, and the probability of the complication is multiplied during repeated treatment [3]. The analysis of the lacrimal sac and nasolacrimal duct biopsies revealed the expression of Na + /Isymporter (NIS) in these structures which may be the biochemical basis for the development of SALDO [4].…”
Section: Discussionmentioning
confidence: 99%
“…According to the study, SALDO occurs in 8.8% of patients after a single high-dose radioactive iodine therapy, and the probability of the complication is multiplied during repeated treatment [3]. The analysis of the lacrimal sac and nasolacrimal duct biopsies revealed the expression of Na + /Isymporter (NIS) in these structures which may be the biochemical basis for the development of SALDO [4].…”
Section: Discussionmentioning
confidence: 99%
“…da Fonseca et al 60 compared the incidence of tear drainage disorders in the patients with thyroid cancer who received and did not receive radioiodine therapy and showed that in the patients after such treatment, the incidence of tear ducts narrowing was 6.8% of cases unlike in the patients of the control group. A telephone survey of patients after radioiodine therapy showed significant tearing in 9% of patients, whereas this symptom frequency increased many times with repeated radioiodine therapy 56 …”
Section: Radioiodine Iodine-131mentioning
confidence: 99%
“…или позднее[8,[11][12][13][14].Описаны случаи развития вторичной облитерации слезоотводящих путей, возникающей в отдаленные сроки (более 6 мес.) после радиойодтерапии[15][16][17][18][19][20][21]. Анализ распространенности этого состояния у пациентов показал, что облитерация слезоотводящих путей развивается в 8% случаев после однократной радиойодтерапии[20].…”
unclassified
“…после радиойодтерапии[15][16][17][18][19][20][21]. Анализ распространенности этого состояния у пациентов показал, что облитерация слезоотводящих путей развивается в 8% случаев после однократной радиойодтерапии[20]. В литературе есть указания на некоторые факторы, ассоциированные с возрастанием риска развития вторичной облитерации слезоотводящих путей после радиойодтерапии, однако эти сведения разрознены, а система стратификации риска на сегодняшний день не разработана.…”
unclassified